Sue Sha

Johnson & Johnson (United States) — United States

Medicine · Health Sciences

18h-index2.0kcitations26works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(15), Pancreatic function and diabetes(12), Diabetes Management and Research(5), Pancreatitis Pathology and Treatment(3), Potassium and Related Disorders(3)

Publications25 total

Reversal of the Anticoagulant Effect of Milvexian By 4-Factor PCC and rFVIIa in Healthy Participants
Blood·2024Open Access
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
Diabetes Obesity and Metabolism·2018· 192 cited
Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials
Diabetes Therapy·2017· 38 citedOpen Access
Effects of Canagliflozin (CANA) on Serum Magnesium (Mg) in Patients With Type 2 Diabetes Mellitus (T2DM)
Canadian Journal of Diabetes·2016· 1 cited
Iconography : Effect of canagliflozin on liver function tests in patients with type 2 diabetes
2015
Effect of canagliflozin on liver function tests in patients with type 2 diabetes
Diabetes & Metabolism·2015· 125 cited
Canagliflozin: a sodium glucose co‐transporter 2 inhibitor for the treatment of type 2 diabetes mellitus
Annals of the New York Academy of Sciences·2015· 89 citedOpen Access
Table of Contents
Clinical Therapeutics·2015Open Access
Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Canagliflozin in Healthy Chinese Subjects
Clinical Therapeutics·2015· 30 cited
Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double‐blind, crossover study
Diabetes Obesity and Metabolism·2014· 91 citedOpen Access
OP42 PHARMACODYNAMIC (PD) DIFFERENCES BETWEEN CANAGLIFLOZIN (CANA) 300 MG AND DAPAGLIFLOZIN (DAPA) 10 MG FOR URINARY GLUCOSE EXCRETION (UGE), RENAL THRESHOLD FOR GLUCOSE (RTG), AND POSTPRANDIAL PLASMA GLUCOSE (PPG) EXCURSION IN HEALTHY PARTICIPANTS
Diabetes Research and Clinical Practice·2014
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants
International Journal of Clinical Pharmacology and Therapeutics·2014· 19 cited
Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes
PLoS ONE·2014· 70 citedOpen Access
Effect of the sodium glucose co‐transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus
Diabetes Obesity and Metabolism·2014· 235 cited
Effect of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, on C‐peptide kinetics
Clinical Pharmacology in Drug Development·2014· 8 cited
Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans
Drug Metabolism and Disposition·2014· 63 cited
Validation of a Novel Method for Determining the Renal Threshold for Glucose Excretion in Untreated and Canagliflozin-treated Subjects With Type 2 Diabetes Mellitus
The Journal of Clinical Endocrinology & Metabolism·2013· 87 citedOpen Access
Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion
Diabetes Care·2013· 259 citedOpen Access
Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary
2013
Canagliflozin, a novel inhibitor of sodium glucose co‐transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects
Diabetes Obesity and Metabolism·2011· 292 cited
page 1 of 2Next →

Frequent Co-authors

David Polidori(15), Paul Rothenberg(11), Nicole Vaccaro(8), Damayanthi Devineni(6), Kristin Farrell(6), Atalanta Ghosh(5), Tim Heise(4), Jaya Natarajan(4), Leona Plum‐Mörschel(4), A. Ghosh(3), Keith T. Demarest(3), Sunder Mudaliar(3), Theodore P. Ciaraldi(3), Robert R. Henry(3), Dainius Balis(3), Mehul Desai(3), Hans Stieltjes(3), Sveta Weiner(3), R. H. A. Becker(2), Thomas Först(2)